Vesynta
London
About Vesynta
Vesynta's technology combines drug monitoring hardware with precision dosing software to provide a universal bedside platform for evidence-based clinical decision support.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $230.7K
- Funding stage: Seed
- Last round: Seed (Apr 2024)
- Website: vesynta.comnews
- Phone: [email protected]
Industries & Categories
Medical
Social Profiles
Canonical: https://fsome.com/organization/vesynta-66122 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.